Michael Brunty

Michael Brunty has over 22 years of contract research experience managing the financial and technical aspects of studies to assess the safety of small molecule pharmaceuticals, biologics, vaccines, agrochemicals, and industrial chemicals. Brunty has extensive experience in resource management and business development.

Prior to joining Inotiv in 2019, Brunty held various technical and managerial positions of increasing responsibility within operations and focused on growing company revenues through the acquisition of commercial and government contracts. In his current role, Brunty is responsible for operational leadership of Inotiv’s facility in Gaithersburg, Maryland, and tasked with optimizing the resources of the site for aggressive growth.

Back to Team